Evolution Summit 2023 - San Diego | Marcus Evans Summits | 11 September 2023 | Park Hyatt Aviara Resort, Golf Club & Spa, 7100 Aviara Resort Drive, Carlsbad, CA 92011, USA

This event is an invitation-only, premium Summit bringing leading clinical trial executives and innovative suppliers and solution providers together. The Summit’s content is aligned with key clinical trial challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.

KEY TOPICS FOR 2023:
• Clearing The Lens On Diversity, Equity & Inclusion
• Positioning The Patient Center Stage
• Reaping Success In Your Sponsor/CRO Partnership
• Exploring The Applicability Of AI In Clinical Research
• Maintaining Trial Execution Excellence Under The New Landscape
• Easing Site Burden

2023 Speakers

COMPELLING PRESENTATIONS:

Rachel Soon
Director, Clinical Innovation, Janssen R&D

John Makowski
Vice President, Head of Clinical Operations, Astellas Gene Therapies

Marco Mancini
Director, Global Development Operations & Portfolio Management, Regeneron Pharmaceuticals

Michael Lim
Executive Director, Oncology Franchise Head, Gilead Sciences, Inc.

Tiffany Valentine
Associate Director, Clinical Operations Evolution Lead, Bristol-Myers Squibb

Sumant Ramachandra, MD, PhD
President & Chief Executive Officer, IMMPACT BIO

Christine Von Raesfeld
Patient Advocate and Founder and CEO, People with Empathy

Estela Mata-Carcamo
Patient Advocate and President, Looms for Lupus, Inc.

INTERACTIVE SESSIONS:

Renee Smith, MBA
Head of Early Development Capabilities and Alliances, The Janssen Pharmaceutical Companies of Johnson & Johnson

Jill Kearney
Global Operations Head, Oncology Early Development, The Janssen Pharmaceutical Companies of Johnson & Johnson

Laura Vessey
Senior Director, Head of Early Development and Clinical Pharmacology, The Janssen Pharmaceutical Companies of Johnson & Johnson

Ting Wang
Senior Director, Clinical Biomarker Operations, Genentech, Inc.

Sidharth Jain
Head, Global Development Data Science, Janssen R&D

Wendy Cheung
Global Head of Oncology Strategy, Operations & New Product Planning, Sanofi

Nishtha Jain
Head of Innovation and Digital Technology, Takeda

Chuck Bradley
SVP, Global Development Operations, Annexon Biosciences

Donna Rycroft
Director, Study Risk Management, Clinical Development Operations, AbbVie

Tara Lehner
VP, Clinical Operations, INmune Bio Inc.

Anna Hassinger
Director, Clinical Operations, Astellas Gene Therapies

Joann Peters
Chief Operating Officer, Geneos Therapeutics

Lisa Tindell
Vice President, Clinical Research Operations, Minneapolis Heart Institute Foundation

Ari Bitton
Director, Clinical Operations, Ascendis Pharma

Denise Windenburg, MHA
Director, Clinical Research Operations Effectiveness, Minneapolis Heart Institute Foundation

Dr Rajbir Singh, MBBS
Executive Director, Precision Medicine and Health Equity Trials Design, Meharry Medical College

Randy Brown
VP, Clinical Operations, Altimmune

Jennifer Gaskin
Senior Director and Head, Clinical Operations, Celldex

Ildiko Csiki
Chief Medical and Strategy Officer, Riboscience

Anil Shanker
SVP, Research and Innovation, Meharry Medical College

DYNAMIC MODERATOR:

Renee Smith
Head of Early Development Capabilities and Alliances, The Janssen Pharmaceutical Companies of Johnson & Johnson

Jill Kearney
Global Operations Head, Oncology Early Development, The Janssen Pharmaceutical Companies of Johnson & Johnson

Laura Vessey
Senior Director, Head of Early Development and Clinical Pharmacology, The Janssen Pharmaceutical Companies of Johnson & Johnson